Search

Your search keyword '"Foucher, Juliette"' showing total 38 results

Search Constraints

Start Over You searched for: Author "Foucher, Juliette" Remove constraint Author: "Foucher, Juliette" Database Academic Search Index Remove constraint Database: Academic Search Index
38 results on '"Foucher, Juliette"'

Search Results

1. Repeated cognitive assessments show stable function over time in patients with ALS.

2. ECAS correlation with metabolic alterations on FDG-PET imaging in ALS.

3. The usage of population and disease registries as pre-screening tools for clinical trials, a systematic review.

4. Validity and reliability measures of the Swedish Karolinska version of the Edinburgh Cognitive and Behavioral ALS Screen (SK-ECAS).

5. International network for ALS research and care (INARC).

6. Longitudinal Liver Stiffness Assessment in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy.

7. Ultraportable Quantitative Ultrasound for Hepatic Steatosis Assessment.

8. A randomized, double‐blind, placebo‐controlled phase 2 study to assess safety, tolerability, and efficacy of RT001 in patients with amyotrophic lateral sclerosis.

9. Long‐term prognosis of patients with metabolic (dysfunction)‐associated fatty liver disease by non‐invasive methods.

10. Long‐term prognosis of patients with alcohol‐related liver disease or non‐alcoholic fatty liver disease according to metabolic syndrome or alcohol use.

11. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter ( CAP) and transient elastography.

12. Feasibility of liver transient elastography with FibroScan® using a new probe for obese patients.

13. Liver stiffness measurement predicts long‐term survival and complications in non‐alcoholic fatty liver disease.

14. New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD.

16. 2014 French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV.

17. Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease.

18. Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease.

19. Liver stiffness measurements for evaluation of central venous pressure in congenital heart diseases.

20. Liver stiffness measurements for evaluation of central venous pressure in congenital heart diseases.

21. MR relaxometry in chronic liver diseases: Comparison of T1 mapping, T2 mapping, and diffusion-weighted imaging for assessing cirrhosis diagnosis and severity.

22. Probability-Based Interpretation of Liver Stiffness Measurement in Untreated Chronic Hepatitis B Patients.

23. Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®).

24. Non-invasive assessment of liver fibrosis with impulse elastography: Comparison of Supersonic Shear Imaging with ARFI and FibroScan®.

25. Controlled attenuation parameter (CAP) for the diagnosis of steatosis: A prospective study of 5323 examinations.

26. Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®).

27. Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C ( ANRS HC16 GAMMATRI).

28. Hepatic Steatosis, Carbohydrate Intake, and Food Quotient in Patients with NAFLD.

29. Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease.

30. Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: Comparison between M and XL probe of FibroScan®

31. A New Combination of Blood Test and Fibroscan for Accurate Non-Invasive Diagnosis of Liver Fibrosis Stages in Chronic Hepatitis C.

32. Evolutionary history of hepatitis C virus genotype 5a in France, a multicenter ANRS study

33. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: Comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores

34. Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C.

35. Outbreak of hepatitis C virus infection during sclerotherapy of varicose veins: Long-term follow-up of 196 patients (4535 patient-years)

36. Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C

37. 76-OR: LIVERFASt Has Similar Performance to Liver Biopsy for the Screening of NASH Fibrosis in T2DM.

38. SAT-288-Liver stiffness measurement predicts long-term survival and complications in non-alcoholic fatty liver disease.

Catalog

Books, media, physical & digital resources